Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.


TSXV:KNE - Post by User

Bullboard Posts
Post by CurlyMickon Mar 11, 2014 1:16pm
199 Views
Post# 22308664

Curious Announcement

Curious AnnouncementI'm a long time holder and trader that wants nothing but the best for Kane, but the conclusion in today's press release is weak. The timing of this 'news' is a bit strange too. Sort of like 'we know you are waiting on the real news, so take this to appease you for now.' 

"Cats on StrixNB as part of their oral care treatment may help to reduce the impact of cat bite wound infections." 

So may is used instead of will because? Could have used might for all it matters in this news.

The estimated savings potential for time and money in Canada or North America vis-a-vis the 1% of emergency rooms visits that are attributable to pet bites and scratches might have proved more fruitful in appeasing me. Actually, any valid quantification would have pleased me...but when terms like 'up to 100%' are used...that still includes zero.

They may just as well have said...you might want to stay away from cats and eliminate the risk completely. 







Bullboard Posts